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S U M M A R Y
Objectives: To determine the molecular epidemiology of seven coxsackievirus A16 (CVA16) strains
previously reported by this research group.
Methods: Full-length VP1 and VP4 sequences were obtained and phylogenetic analyses were performed.
Results: Six strains were classiﬁed as genotype C. Moreover, one divergent strain not clustered in any of
the three currently reported genotypes was found.
Conclusion: This is the ﬁrst report of CVA16 in Peru and provides valuable baseline data about its
potential distribution in South America, as well as evidence of a potential divergent genotype that has
never before been reported.
 2016 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Coxsackievirus A16 (CVA16) belongs to the genus Enterovirus,
family Picornaviridae, and was ﬁrst isolated in South Africa in
1955.1 CVA16 infections can be associated with a wide variety of
complications including death.1–3
The classiﬁcation of CVA16 is not yet well established.
Molecular characterization is carried out based on the VP1 gene,
which encodes a protein with immunogenic functionality and is
important in antigenic characterization .4,5 Based on VP1, CVA16
has been classiﬁed into three genotypes: A, B, and C.5–7
The molecular epidemiology of CVA16 outside Asia is mostly
unknown, particularly in the Americas. This fact has limited the
ability of investigators to explore the questions of the origin and
divergent patterns of CVA16 genotypes. Prior to May 30, 2016,
GenBank searches revealed only partial VP1 sequences from
Argentina and the USA. It was thus sought to characterize the
genetic diversity and molecular epidemiology of CVA16 in Peru
and to determine how this compares to other regions of the world.* Corresponding author. Tel.: +51 1 614 4141 ext 150; fax: +51 614 4174.
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creativecommons.org/licenses/by-nc-nd/4.0/).2. Methods
CVA16 was isolated from nasopharyngeal swabs. Isolation and
identiﬁcation were performed and reported by the team using cell
culture, immunoﬂuorescence, and reverse transcription PCR (RT-
PCR).8 Full-length VP1 and VP4 sequences of the seven CVA16
strains were ampliﬁed by RT-PCR using the primers and cycle
conditions as described previously.7,9
Genetic diversity was analyzed using complete sequences of
both the VP1 and VP4 genes. Phylogenetic trees were recon-
structed using the Maximum Likelihood algorithm in MEGA
software (version 5.2.2). The pairwise distance was calculated with
the Kimura 2-parameter model of nucleotide substitution and a
bootstrap analysis with 1000 replicates. All analytical procedures
were repeated by a blinded operator using the original samples.
3. Results
As a result of previous passive, clinic-based surveillance
activities throughout Peru,10 seven CVA16 isolates reported
between 2005 and 2010 were collected and identiﬁed.8 Table 1
presents the demographic and clinical information for these seven
CVA16 strains. Four of the isolates were collected in 2009. Isolates
were collected in four Peruvian provinces: two coastal regionious Diseases. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Clinical and demographic information for Peruvian CVA16 isolates
Code Latitude/longitude Month and year Location Age (years) Sex Symptoms
FLU3370 5.19/  80.62 Mar 2006 Piura 2 M FV, MA, ST
FLA1135 16.41/  71.53 Feb 2008 Arequipa <1 F FV, MA, ST, R
FLA4791 5.19/  80.62 Nov 2008 Piura 2 M FV, C, MA, A, R
FLA6014 5.19/  80.62 Feb 2009 Piura <1 F FV, C, MA, R
FLA6784 12.07/  77.06 Apr 2009 Lima 1 M FV, C, ST, H, R
FLA6916 3.74/  73.25 Apr 2009 Loreto 3 M FV, C, E, MA, A, ST, R, D
FLA8485 12.10/  76.96 Jun 2009 Lima 6 F FV, C, ST, H, R, D
CVA16, coxsackievirus A16; M, male; F, female; FV, fever; MA, malaise; ST, sore throat; R, rhinorrhea; C, cough; A, asthenia; H, headache; E, expectoration; D, diarrhea.
Figure 1. Maximum likelihood trees of coxsackievirus A16 isolates based on: (a) full-length VP1 (891 bp) sequences, and (b) full-length VP4 (207 bp) sequences. Only
bootstrap values >70% are shown at the nodes. Representative strains of genogroups A, B, and C were included. Sequences are named as follows: accession number, location,
and year. Peruvian coxsackievirus A16 strains are in red. Enterovirus 71 was used to root the tree.
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(Arequipa), and one jungle region province (Iquitos). Six of the
seven participants were less than 5 years of age.
Full-length VP1 sequences were obtained for the seven strains;
however, due to an insufﬁcient amount of sample, only six
full-length VP4 sequences were obtained. All sequences weresubmitted to the GenBank database under the following accession
numbers: VP1 KF956714–KF956720, VP4 KJ010766–KJ010771.
Based on the full-length VP1 sequence, it was found that six
isolates clustered in the same lineage and were separate from
Asian, European, and Australian strains. All six of these strains
grouped together within genotype C (Figure 1a). However, the
G. Carrion et al. / International Journal of Infectious Diseases 52 (2016) 83–85 85remaining isolate (FLA6916) from Iquitos did not cluster within a
known genotype; it actually demonstrated a divergent pattern
when compared with genotypes B and C. Phylogenetic analysis
using the full-length VP4 gene showed the same relationship as
was observed using complete VP1 (Figure 1b).
Recombination screening by RDP3 did not reveal local
recombination, although the total Peruvian dataset was small
and the whole genome was not sequenced.
4. Discussion
This study presents the ﬁrst report of the molecular characteri-
zation of CVA16 strains in Peru. The ﬁndings revealed multiple co-
circulating clades in genotype C .The molecular epidemiology of
CVA16 in Peru during the years 2006–2009 reﬂects a pattern of the
circulation of genotype C. It was noted that the Peruvian strains
from multiple locations (Lima, Piura, and Arequipa) fell into a well-
supported Peruvian clade with spatial and temporal clustering.
This potentially reﬂects some localization of CVA16 spread.
Interestingly, there was evidence of CVA16 persistence in Peru,
with the 2006 taxa forming a well-supported clade with those
collected in later years. The single isolate (FLA6916) collected from
Iquitos, the largest and most populous city in the Peruvian
Amazon, was discovered to be highly divergent from other
Peruvian strains and all other genotype B and C strains.
Recombination as the cause of this possible divergence is not
likely because enterovirus does not recombine within the VP1 gene
(except for homologous recombination); recombination in the P1
(capsid) region is most often deleterious and likely fatal to the
virus.5
Two possible inferences can be drawn as to why this divergence
may have occurred. First, the molecular epidemiology of CVA16 in
the Amazon basin compared with the rest of Peru may be uniquely
distinct, allowing for the emergence of novel strains. Second, this
isolate may have been introduced independently into Iquitos by
outside travelers. Gathering additional isolates will help elucidate
the more complete epidemiology of CVA16 in Peru and surround-
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